Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETOPOSIDE vs EXEMESTANE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ETOPOSIDE vs EXEMESTANE: Safety Overview

Metric ETOPOSIDE EXEMESTANE
Total FAERS Reports 52,603 10,418
Deaths Reported 11,780 1,256
Death Rate 22.4% 12.1%
Hospitalizations 17,699 2,327
Average Patient Age 42.5 yrs 64.2 yrs
% Female Patients 41.8% 98.7%
FDA Approval Date Aug 30, 1995 Apr 1, 2011
Manufacturer Avyxa Pharma, LLC Zydus Lifesciences Limited
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription